Life Science Washington President & CEO Partners with Other Life Science Association Leaders to Oppose NIH Funding Cuts and Defend US Leadership in Biotechnology

NIH funding is critical to maintaining American competitiveness and economic success. The Trump Administration’s proposed cuts to NIH’s indirect cost reimbursement threaten to undermine American exceptionalism, ceding our leadership in life sciences, global health, and biosecurity to China. 

In a new op-ed for the Timmerman Report, Life Science Washington President and CEO Marc Cummings and other state biotech association leaders call on the Trump Administration to drop the case regarding NIH cuts and start a meaningful dialogue with industry and research leaders to maintain our position as the world’s dominant life science powerhouse.